wu
polyomaviru
recent
describ
polyomaviru
found
patient
respiratori
infect
respiratori
sampl
test
st
loui
missouri
posit
wu
polyomaviru
pcr
coinfect
respiratori
virus
persist
human
infect
wu
polyomaviru
describ
n
initi
report
describ
identifi
cation
wu
polyomaviru
respiratori
tract
sampl
collect
st
loui
missouri
usa
respiratori
tract
specimen
test
brisban
queensland
australia
goal
studi
extend
initi
fi
nding
determin
preval
wu
polyomaviru
larger
patient
cohort
st
loui
test
nasopharyng
swab
nasal
wash
patient
day
year
age
submit
virolog
laboratori
st
loui
children
hospit
routin
respiratori
viru
detect
juli
june
sampl
children
year
age
includ
newborn
children
year
age
specimen
extract
autom
roch
magna
pure
lc
extractor
magna
pure
lc
total
nucleic
acid
isol
kit
roch
diagnost
indianapoli
usa
realtim
pcr
amplifi
cation
primer
minor
groov
binder
probe
use
commerci
avail
univers
taqman
realtim
pcr
master
mix
abi
realtim
thermocycl
appli
biosystem
foster
citi
ca
usa
wu
polyomavirusposit
specimen
screen
addit
virus
infl
uenza
b
rsv
b
piv
human
metapneumoviru
adenoviru
subgroup
b
c
e
rhinoviru
coronavirus
use
eragen
multicodeplx
respiratori
viru
panel
describ
previous
clinic
specimen
assign
code
collect
clinic
data
approv
washington
univers
human
research
protect
offi
ce
pertin
demograph
histor
clinic
inform
avail
collect
use
standard
collect
form
statist
signifi
canc
determin
use
fisher
exact
test
epi
info
softwar
version
center
diseas
control
prevent
atlanta
ga
usa
seventi
test
specimen
posit
wu
polyomaviru
posit
sampl
also
posit
respiratori
viru
posit
sampl
omit
analysi
chart
unavail
remain
sampl
collect
individu
patient
specimen
serial
sampl
associ
distinct
clinic
syndrom
immunocompromis
patient
wuposit
patient
femal
ethnic
breakdown
follow
africanamerican
caucasian
posit
specimen
note
patient
day
year
age
onlin
appendix
tabl
avail
highest
lowest
rate
infect
display
figur
patient
posit
wu
polyomaviru
detect
throughout
year
small
peak
observ
juli
second
small
peak
observ
april
may
figur
panel
b
wu
polyomaviru
viru
detect
fullterm
infant
deliv
cesarean
section
transfer
st
loui
children
hospit
respiratori
distress
requir
intub
afebril
lung
opac
chest
radiograph
patent
ductu
arteriosu
pulmonari
hypertens
eventu
diagnos
oldest
patient
posit
wu
polyomaviru
cohort
immunosuppress
includ
evan
syndrom
sever
combin
immunodefi
cienci
syndrom
postbon
marrow
transplant
endstag
renal
diseas
asthma
common
clinic
fi
nding
patient
wu
polyomaviru
list
tabl
frequent
diagnos
pneumonia
although
posit
bacteri
cultur
bronchiol
upper
respiratori
tract
infect
also
compar
measur
paramet
patient
infect
wu
alon
patient
coinfect
virus
case
statist
signifi
cohort
sampl
includ
sever
set
sequenti
sampl
taken
patient
cours
prolong
ill
patient
sequenti
sampl
obtain
span
week
posit
wu
polyomaviru
fi
rst
patient
girl
hemophagocyt
lymphohistiocytosi
distinct
respiratori
specimen
test
posit
period
fi
rst
posit
specimen
obtain
asymptomat
admiss
bone
marrow
transplant
septemb
second
sampl
obtain
clinic
visit
nasal
congest
cough
novemb
third
sampl
also
posit
coronaviru
obtain
admiss
day
later
pneumonia
final
fourth
sampl
neg
previous
detect
coronaviru
taken
day
later
admiss
episod
apnea
second
patient
child
biliari
atresia
admit
liver
transplant
septemb
posit
sampl
period
initi
sampl
taken
admiss
neg
wu
polyomaviru
six
week
transplant
fever
short
breath
requir
intub
develop
sampl
taken
posit
wu
polyomaviru
adenoviru
four
week
later
worsen
short
breath
fever
develop
blood
cultur
also
posit
klebsiella
enterobact
spp
third
respiratori
sampl
demonstr
wu
polyomaviru
rhinoviru
two
week
later
fever
hypoxia
increas
secret
develop
fourth
sampl
posit
wu
polyomaviru
followup
sampl
obtain
month
later
patient
indic
clearanc
wu
viru
patient
infect
wu
polyomaviru
cohort
primarili
hospit
pneumonia
bronchiol
upper
respiratori
tract
infect
one
new
observ
multipl
respiratori
specimen
sampl
patient
week
posit
wu
polyomaviru
suggest
wu
polyomaviru
may
persist
infect
human
patient
immunocompromis
although
abl
clear
infect
virus
coronaviru
rhinoviru
adenoviru
suggest
continu
detect
wu
polyomaviru
due
complet
incapacit
immun
system
sequenc
analysi
fragment
gene
wu
polyomaviru
amplifi
ed
multipl
sampl
patient
show
sequenc
polymorph
initi
later
sampl
data
shown
sequenc
variat
previous
report
locu
data
consist
model
persist
infect
detect
wu
polyomaviru
respiratori
secret
infant
suggest
vertic
transmiss
wu
polyomaviru
mother
fetu
may
occur
although
studi
need
verifi
suggest
conclus
wu
polyomaviru
detect
patient
respiratori
tract
infect
high
percentag
coinfect
respiratori
virus
detect
complic
interpret
clinic
fi
nding
howev
wu
polyomaviru
sole
viru
detect
specimen
patient
respiratori
ill
suggest
may
respiratori
pathogen
final
observ
persist
viru
suggest
analog
bk
jc
virus
regard
